Advancement of the 10-species subgingival Zurich Biofilm model by examining different nutritional conditions and defining the structure of the in vitro biofilms

BMC Microbiology

Thomas Thurnheer¹  Rudolf Gmür¹  Thomas W Ammann¹ 

[1] Section of Oral Microbiology and Immunology, Institute of Oral Biology, Center of Dental Medicine, Plattenstrasse 11, 8032, Zürich, Switzerland

关键词: IF;    FISH;    CLSM;    Structure;    Subgingival;    Biofilm;    Model;    Periodontitis;   

Others  :  1221726
DOI  :  10.1186/1471-2180-12-227

 received in 2012-04-13, accepted in 2012-10-04,  发布年份 2012

【 摘 要 】

Background

Periodontitis is caused by a highly complex consortium of bacteria that establishes as biofilms in subgingival pockets. It is a disease that occurs worldwide and its consequences are a major health concern. Investigations in situ are not possible and the bacterial community varies greatly between patients and even within different loci. Due to the high complexity of the consortium and the availability of samples, a clear definition of the pathogenic bacteria and their mechanisms of pathogenicity are still not available. In the current study we addressed the need of a defined model system by advancing our previously described subgingival biofilm model towards a bacterial composition that reflects the one observed in diseased sites of patients and analysed the structure of these biofilms.

Results

We further developed the growth media by systematic variation of key components resulting in improved stability and the firm establishment of spirochetes in the 10-species subgingival Zurich biofilm model. A high concentration of heat-inactivated human serum allowed the best proliferation of the used species. Therefore we further investigated these biofilms by analysing their structure by confocal laser scanning microscopy following fluorescence in situ hybridisation. The species showed mutual interactions as expected from other studies. The abundances of all organisms present in this model were determined by microscopic counting following species-specific identification by both fluorescence in situ hybridisation and immunofluorescence. The newly integrated treponemes were the most abundant organisms.

Conclusions

The use of 50% of heat-inactivated human serum used in the improved growth medium resulted in significantly thicker and more stable biofilms, and the quantitative representation of the used species represents the in vivo community of periodontitis patients much closer than in biofilms grown in the two media with less or no human serum. The appearance of T. denticola, P. gingivalis, and T. forsythia in the top layer of the biofilms, and the high abundance of T. denticola, reflects well the microbial situation observed at diseased sites. The improved model biofilms will allow further investigations of interactions between individual species and of the effects of atmospheric or nutritional changes, as well as interactions with tissue cells.

【 授权许可】

   
2012 Ammann et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】

• [1]Flemming HC: The perfect slime. Colloid Surface B 2011, 86:251-259.
• [2]Jenkinson HF: Beyond the oral microbiome. Environ Microbiol 2011, 13:3077-3087.
• [3]Marsh PD, Percival RS: The oral microflora - friend or foe? Can we decide? Int Dent J 2006, 56:233-239.
• [4]Van Dyke TE, Sheilesh D: Risk factors for periodontitis. J Int Acad Periodontol 2005, 7:3-7.
• [5]Li XJ, Kolltveit KM, Tronstad L, Olsen I: Systemic diseases caused by oral infection. Clin Microbiol Rev 2000, 13:547-558.
• [6]Socransky SS, Haffajee AD: Dental biofilms: difficult therapeutic targets. Periodontol 2002, 28:12-55.
• [7]Paster BJ, Olsen I, Aas JA, Dewhirst FE: The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2006, 42:80-87.
• [8]Zijnge V, Ammann T, Thurnheer T, Gmür R: Subgingival biofilm structure. Edited by Mombelli A, Kinane DF. Basel: Karger; 2012:1-16. [Frontiers of Oral Biology]
• [9]Shaddox LM, Alfant B, Tobler J, Walker C: Perpetuation of subgingival biofilms in an in vitro model. Mol Oral Microbiol 2010, 25:81-87.
• [10]Hope CK, Wilson M: Biofilm structure and cell vitality in a laboratory model of subgingival plaque. J Microbiol Methods 2006, 66:390-398.
• [11]Guggenheim B, Gmür R, Galicia JC, Stathopoulou PG, Benakanakere MR, Meier A, Thurnheer T, Kinane DF: In vitro modeling of host-parasite interactions: the 'subgingival' biofilm challenge of primary human epithelial cells. BMC Microbiol 2009, 9:280. BioMed Central Full Text
• [12]Guggenheim B, Giertsen E, Schupbach P, Shapiro S: Validation of an in vitro biofilm model of supragingival plaque. J Dent Res 2001, 80:363-370.
• [13]Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R, Harmsen HJ: Oral biofilm architecture on natural teeth. PLoS One 2010, 5:e9321.
• [14]Kolenbrander PE, London J: Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 1993, 175:3247-3252.
• [15]Ruiz V, Rodriguez-Cerrato V, Huelves L, Del Prado G, Naves P, Ponte C, Soriano F: Adherence of streptococcus pneumoniae to polystyrene plates and epithelial cells and the antiadhesive potential of albumin and xylitol. Pediatr Res 2011, 69:23-27.
• [16]Naves P, del Prado G, Huelves L, Rodriguez-Cerrato V, Ruiz V, Ponte MC, Soriano F: Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains. J Hosp Infect 2010, 76:165-170.
• [17]Hojo K, Nagaoka S, Ohshima T, Maeda N: Bacterial interactions in dental biofilm development. J Dent Res 2009, 88:982-990.
• [18]Wyss C: Growth of Porphyromonas gingivalis, Treponema denticola, T. pectinovorum, T. socranskii, and T. vincentii in a chemically defined medium. J Clin Microbiol 1992, 30:2225-2229.
• [19]Thurnheer T, Gmür R, Shapiro S, Guggenheim B: Mass transport of macromolecules within an in vitro model of supragingival plaque. Appl Environ Microbiol 2003, 69:1702-1709.
• [20]Kesavalu L, Holt SC, Ebersole JL: Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model. Oral Microbiol Immun 1998, 13:373-377.
• [21]Orth RK, O'Brien-Simpson NM, Dashper SG, Reynolds EC: Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol Oral Microbiol 2011, 26:229-240.
• [22]Grenier D: Nutritional Interactions between Two Suspected Periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect Immun 1992, 60:5298-5301.
• [23]Ito R, Ishihara K, Shoji M, Nakayama K, Okuda K: Hemagglutinin/Adhesin domains of Porphyromonas gingivalis play key roles in coaggregation with Treponema denticola. FEMS Immunol Med Microbiol 2010, 60:251-260.
• [24]Sharma A, Inagaki S, Sigurdson W, Kuramitsu HK: Synergy between Tannerella forsythia and Fusobacterium nucleatum in biofilm formation. Oral Microbiol Immunol 2005, 20:39-42.
• [25]Amann RI, Ludwig W, Schleifer KH: Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 1995, 59:143-169.
• [26]Pernthaler A, Pernthaler J, Amann R: Fluorescence in situ hybridization and catalyzed reporter deposition for the identification of marine bacteria. Appl Environ Microbiol 2002, 68:3094-3101.
• [27]Fuchs BM, Glockner FO, Wulf J, Amann R: Unlabeled helper oligonucleotides increase the in situ accessibility to 16S rRNA of fluorescently labeled oligonucleotide probes. Appl Environ Microbiol 2000, 66:3603-3607.
• [28]Fuchs BM, Syutsubo K, Ludwig W, Amann R: In situ accessibility of Escherichia coli 23S rRNA to fluorescently labeled oligonucleotide probes. Appl Environ Microbiol 2001, 67:961-968.
• [29]Milner P, Batten JE, Curtis MA: Development of a simple chemically defined medium for Porphyromonas gingivalis: requirement for alpha-ketoglutarate. FEMS Microbiol Lett 1996, 140:125-130.
• [30]Blakemore RP, Canale-Parola E: Arginine catabolism by Treponema denticola. J Bacteriol 1976, 128:616-622.
• [31]Wyss C: Fatty acids synthesized by oral treponemes in chemically defined media. FEMS Microbiol Lett 2007, 269:70-76.
• [32]Thurnheer T, Gmür R, Guggenheim B: Multiplex FISH analysis of a six-species bacterial biofilm. J Microbiol Methods 2004, 56:37-47.
• [33]Guggenheim M, Shapiro S, Gmür R, Guggenheim B: Spatial arrangements and associative behavior of species in an in vitro oral biofilm model. Appl Environ Microbiol 2001, 67:1343-1350.
• [34]Thurnheer T, Gmur R, Giertsen E, Guggenheim B: Automated fluorescent in situ hybridization for the specific detection and quantification of oral streptococci in dental plaque. J Microbiol Methods 2001, 44:39-47.
• [35]Züger J, Lüthi-Schaller H, Gmür R: Uncultivated Tannerella BU045 and BU063 are slim segmented filamentous rods of high prevalence but low abundance in inflammatory disease-associated dental plaques. Microbiology 2007, 153:3809-3816.
• [36]Gmür R: Value of new serological probes for the study of putative periodontal pathogens. Zurich: Dental Center of the University of Zurich; 1995:86.
• [37]Werner-Felmayer G, Guggenheim B, Gmür R: Production and characterization of monoclonal antibodies against Bacteroides forsythus and Wolinella recta. J Dent Res 1988, 67:548-553.
• [38]Gmür R, Werner-Felmayer G, Guggenheim B: Production and characterization of monoclonal antibodies specific for Bacteroides gingivalis. Oral Microbiol Immunol 1988, 3:181-186.
• [39]Gmür R, Guggenheim B: Antigenic heterogeneity of Bacteroides intermedius as recognized by monoclonal antibodies. Infect Immun 1983, 42:459-470.
• [40]Thurnheer T, Guggenheim B, Gruica B, Gmür R: Infinite serovar and ribotype heterogeneity among oral Fusobacterium nucleatum strains? Anaerobe 1999, 5:79-92.
• [41]Thurnheer T, Guggenheim B, Gmür R: Characterization of monoclonal antibodies for rapid identification of Actinomyces naeslundii in clinical samples. FEMS Microbiol Lett 1997, 150:255-262.